Insight Molecular Diagnostics Inc. Cash Flow Quality Index

Latest as of March 2023: -2.74x

Insight Molecular Diagnostics Inc. cash flow quality index. Insight Molecular Diagnostics Inc. (IMDX) has a Cash Flow Quality Index of -2.74x as of March 2023. Operating cash flow of $-8.30 Million is below net income of $3.03 Million, suggesting accrual-heavy earnings not yet converted to cash. See IMDX financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-2.74x
Operating CF / Net Income

Operating Cash Flow

$-8.30 Million
USD

Net Income

$3.03 Million
USD

Data as of

Mar 2023
Most recent filing

Insight Molecular Diagnostics Inc. Cash Flow Quality Index by Year (None–None)

Insight Molecular Diagnostics Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Insight Molecular Diagnostics Inc.. For the full cash flow conversion analysis, see Insight Molecular Diagnostics Inc. cash conversion from operations.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.